LENZ Therapeutics, Inc.

Ownership Transactions Reported by 29 Insiders

Symbol
LENZ on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
201 Lomas Santa Fe Drive, Suite 300, Solana Beach, CA

There are no Buy or Sell transactions made by insiders since 12/22/2023

LENZ Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
EcoR1 Capital, LLC 10%+ Owner $34.8M Jan 6, 2023
Samsara BioCapital, L.P. 10%+ Owner $34.7M Apr 11, 2022
Ra Capital Management, L.P. Director, 10%+ Owner $13.5M Mar 21, 2024
Versant Venture Capital VI, L.P. 10%+ Owner $12M Mar 21, 2024
Versant Venture Capital VII, L.P. 10%+ Owner $6.52M Mar 21, 2024
James W. Mccollum Director $2.4M May 13, 2024
Phil Gutry Chief Business Officer $1.22M Apr 11, 2022
Katherine V. Stultz Chief Operating Officer $881K Jun 24, 2021
Marc Odrich Chief Medical Officer $406K Mar 21, 2024
Evert B. Schimmelpennink President, CEO and Secretary, Director $93.6K Jul 22, 2024
Shawn Olsson Chief Commercial Officer $6.93K Dec 16, 2024
Daniel R. Chevallard Chief Financial Officer $6.63K May 14, 2024
Davis Jerel Director Jul 19, 2023
Alethia Young Chief Financial Officer Feb 21, 2023
Joseph Jimenez Director Jul 19, 2023
Smital Shah Director Jul 19, 2023
Perry A. Karsen Director Jul 19, 2023
Kristen Hege Director Jul 19, 2023
Joanne L. Viney Director Jul 19, 2023
Joshua Lehrer-Graiwer PRESIDENT AND CEO, Director Feb 21, 2023
Matthew Porteus Director Jul 19, 2023
Rizzuto Carlo Director Jul 19, 2023
Abraham Bassan Director Jul 19, 2023
Alpha Wave Ventures GP, Ltd 10%+ Owner Mar 21, 2024
Shelley Thunen Director Mar 21, 2024
Jeffrey P. George Director Mar 21, 2024
Kimberlee C. Drapkin Director Mar 21, 2024
Zachary Scheiner Director Mar 21, 2024
Frederic Guerard Director Mar 21, 2024

Recent Insider Transactions by Companies or Individuals for LENZ Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.